Conditions · Obstetrics and gynecology
Intrahepatic cholestasis of pregnancy !
A liver problem of late pregnancy causing intense itching of palms and soles from raised bile acids. It goes away after birth but can harm the baby.
Updated 2026-11-01
Structures involved
Tap one to see what it is and open it in 3D.
Why it happens
What it is
A pregnancy-specific liver disorder in which bile flow is reduced and bile acids accumulate in the mother’s blood. It typically appears in the late second or third trimester with generalised itching without a primary rash, and resolves after delivery. Its importance lies in the fetal risks.
Who gets it
The most common liver disease specific to pregnancy. Frequency varies widely by ethnicity and region: in many countries it affects under 1% of pregnancies, while Chile and Bolivia have historically reported some of the highest rates in the world, especially in Indigenous women. It recurs in a large share of later pregnancies.
Causes
- High levels of oestrogen and progesterone metabolites in late pregnancy, which impair bile transport
- Genetic predisposition: variants in hepatocyte bile transporter genes (ABCB4 is the most important; also ABCB11, ATP8B1)
- Environmental factors (seasonal variation, low selenium and vitamin D have been suggested)
Risk factors
- Previous pregnancy with cholestasis
- Family history (mother or sister)
- Multiple pregnancy
- In vitro fertilisation
- Advanced maternal age
- Chronic hepatitis C or other pre-existing liver disease
- Ethnic background (Chilean and Andean Indigenous ancestry)
Pathophysiology
Pregnancy hormones and their metabolites, in women with genetically less efficient canalicular transporters, reduce the secretion of bile acids from hepatocytes into the bile. Bile acids accumulate in maternal blood, causing itching, and cross the placenta. In the fetus, high bile acids can cause cardiac arrhythmias, constriction of placental vessels and stimulation of the colon and myometrium, which explains meconium-stained fluid, preterm labour and sudden intrauterine death. Fat malabsorption can lower vitamin K.
Classification
- Mild: total serum bile acids raised but below 40 µmol/L
- Severe: total serum bile acids 40 µmol/L or more
- Very high risk: total serum bile acids 100 µmol/L or more (stillbirth risk rises sharply)
Symptoms and signs
- Itching, often intense and worse at night, typically starting on the palms and soles and then spreading
- No primary rash; only scratch marks (excoriations)
- Insomnia and fatigue from itching
- Mild jaundice in a minority, usually after the itching
- Dark urine or pale stools occasionally
Diagnosis
- Clinical
- Pruritus without a rash in the second half of pregnancy, with raised serum bile acids and no other explanation, and resolution after delivery.
- Tests
- Total serum bile acids (key test; ideally non-fasting and repeated); liver transaminases are often raised. Rule out other causes: viral hepatitis serology, autoimmune liver markers. Prothrombin time if there is steatorrhoea or severe disease. Repeat liver tests after delivery to confirm normalisation.
- Imaging
- Liver and biliary ultrasound to exclude gallstones or biliary obstruction; it is normal in cholestasis of pregnancy.
Differential diagnosis
- Gallstones with biliary obstruction
- Viral hepatitis
- Preeclampsia and HELLP syndrome
- Acute fatty liver of pregnancy
- Primary biliary cholangitis or other chronic cholestatic disease
- Pregnancy dermatoses (polymorphic eruption, pemphigoid gestationis) and atopic eruption
Goal of treatment
Relieve maternal itching, lower bile acid levels and reduce fetal risk through surveillance and well-timed delivery.
Treatment
- Medical
- Ursodeoxycholic acid is the usual first-line drug: it improves itching and liver tests. Topical emollients and some antihistamines are used for symptom relief.
- Follow-up
- Serial bile acids and liver tests, fetal surveillance and teaching the mother to report reduced fetal movements.
- Procedure
- Planned delivery timed by bile acid level: usually around 38–39 weeks in mild disease, earlier (around 35–36 weeks) in very severe disease, with antenatal corticosteroids if preterm.
- Medical
- Vitamin K supplementation if prothrombin time is prolonged or there is fat malabsorption.
- Conservative
- Cool clothing, lukewarm baths and short nails to limit skin damage from scratching.
Complications
- Stillbirth (risk rises with bile acids at or above 100 µmol/L)
- Spontaneous preterm birth and iatrogenic preterm delivery
- Meconium-stained amniotic fluid and fetal distress
- Neonatal respiratory distress
- Associated maternal gestational diabetes and preeclampsia
- Recurrence in later pregnancies and higher lifetime risk of gallstones and hepatobiliary disease
Prognosis
For the mother it is benign: itching usually stops within days of delivery and liver tests normalise within weeks. Fetal outcome is good with surveillance and timely delivery. Recurrence in a later pregnancy is common, and symptoms may appear with combined hormonal contraceptives.
Prevention
- Cannot be prevented
- Women with a previous episode should have early bile acid testing if itching appears in a later pregnancy
Test yourself
Think of the answer, then tap the question to see it.
What is the classic presentation of intrahepatic cholestasis of pregnancy?
Intense itching of the palms and soles, worse at night, in the third trimester, without a primary rash.
What is the key laboratory test?
Total serum bile acids, which are raised; transaminases may also be raised.
What is the most feared complication?
Sudden intrauterine fetal death, especially when bile acids are 100 µmol/L or more.
What is the first-line drug for itching?
Ursodeoxycholic acid.
Which South American country has historically reported one of the highest rates?
Chile (also Bolivia), particularly in women of Indigenous ancestry.
Related conditions
- Acute fatty liver of pregnancy
- HELLP syndrome
- Preeclampsia
- Viral hepatitis
- Gallstones (cholelithiasis)
- Stillbirth (intrauterine fetal death)
- Preterm labour and birth
- Gestational diabetes mellitus
Educational information, not medical advice. For any symptom, see a health professional.
Sources: Intrahepatic cholestasis of pregnancy (MedlinePlus Genetics (U.S. National Library of Medicine), 2024); Cholestasis of Pregnancy (Cleveland Clinic, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.